Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00675753 · ClinicalTrials.gov registry record

Three Interacting Single Nucleotide Polymorphisms (SNPs) and the Risk of Preterm Birth in Black Families

A clinical trial, sponsored by University of Miami.

Terminated
Registry status
258
Enrollment target

NCT00675753 is a clinical trial that was terminated before completion, run by University of Miami. The registered enrollment target is 258 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00675753 was terminated before completion, sponsored by University of Miami.

TERMINATED
Registry status
258 participants
Enrollment target

Study Summary

A multilocus interaction of three pro-inflammatory cytokine single nucleotide polymorphisms (SNPs), -3448 Tumor Necrosis Factor-α, -7227 Interleukin 6, and 33314 Interleukin 6R was reported by Menon and associates in 2006. The researchers reported that they were able to predict spontaneous preterm birth in 65.2% of a population restricted to European-American mothers. Expansion of this research is needed to determine if the results are also applicable in Black populations. Statement of Purpose The purpose of this research is to determine if the multi-locus genetic interaction of tumor necrosis factor-α (-3448), interleukin 6 (-7227), and interleukin 6R (33314), as described by Menon et al. (2006), is associated with preterm birth in Black mother-infant dyads. Research Aims and Hypotheses: Primary Aim 1.0: To determine if carriage of one of the high risk genetic patterns, as identified by Menon et al. (2006), is present in 65% of Black mothers with preterm births and 35% of Black mothers with term births. Hypothesis 1.0: There is no statistically significant difference in the occurrence of one of the eight high risk genetic patterns, as identified by Menon et al. (2006), in a population of Black mothers with preterm births (case) and Black mothers with term births (controls). Primary Aim 2.0: To determine if carriage of one of the high risk genetic patterns, as identified by Menon et al. (2006), is present in 65% of Black preterm newborns and 35% of Black term newborns. Hypothesis 2.0: There is no statistically significant difference in the occurrence of one of the eight high risk genetic patterns, as identified by Menon et al. (2006), in a population of Black preterm newborns (case) and Black term newborns (controls).

Interventions

  • GENETIC Blood spot specimens will be drawn

Trial Details

FieldValue
Enrollment Target 258 participants
Start Date 2008-09
Est. Completion 2009-08

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT00675753

The ClinicalTrials.gov registry entry for NCT00675753 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Blood spot specimens will be drawn is the first listed.

NCT00675753 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00675753 about?

NCT00675753 is a clinical study titled "Three Interacting Single Nucleotide Polymorphisms (SNPs) and the Risk of Preterm Birth in Black Families". A multilocus interaction of three pro-inflammatory cytokine single nucleotide polymorphisms (SNPs), -3448 Tumor Necrosis Factor-α, -7227 Interleukin 6, and 33314 Interleukin 6R was reported by Menon and associates in 2006. The researchers reported that they were able to predict spontaneous preterm b...

What is the current status of trial NCT00675753?

This trial is currently terminated. The enrollment target is 258 participants. The study started on 2008-09. Estimated completion is 2009-08.

What interventions are being tested in trial NCT00675753?

The interventions under investigation include: Blood spot specimens will be drawn (GENETIC).

Who is sponsoring clinical trial NCT00675753?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.